diazooxonorleucine has been researched along with deoxyglucose in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, G; Guskey, LE | 1 |
| Crawford, M; Griffiths, M; Keast, D; Palmer, TN; Patrick, G | 1 |
| Andrade-Oliveira, V; Bowman, CE; Brandacher, G; Cheng, CH; Furtmüller, GJ; Lee, CF; Lo, YC; Oh, B; Powell, JD; Slusher, BS; Thomas, AG; Wolfgang, MJ | 1 |
| Brandacher, G; Cheng, CH; Furtmüller, GJ; Lee, CF; Oh, BC; Patel, CH; Powell, JD | 1 |
4 other study(ies) available for diazooxonorleucine and deoxyglucose
| Article | Year |
|---|---|
Poliovirus and vesicular stomatitis virus replication in the presence of 6-diazo-5-oxo-L-norleucine or 2-deoxy-D-glucose.
Topics: Animals; Azo Compounds; Cell Line; Chlorocebus aethiops; Deoxy Sugars; Deoxyglucose; Diazooxonorleucine; Glutamine; Humans; Kinetics; Nucleotides; Poliovirus; RNA; RNA, Viral; Tunicamycin; Uridine; Vesicular stomatitis Indiana virus; Viral Plaque Assay; Virus Replication | 1984 |
The role of glutamine and glucose analogues in metabolic inhibition of human myeloid leukaemia in vitro.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Deoxyglucose; Diazooxonorleucine; Humans; Isoxazoles; Leukemia, Myeloid; Tumor Cells, Cultured | 1993 |
Preventing Allograft Rejection by Targeting Immune Metabolism.
Topics: Allografts; Animals; CD8-Positive T-Lymphocytes; Cells, Cultured; Deoxyglucose; Diazooxonorleucine; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glutamine; Glycolysis; Graft Rejection; Heart Transplantation; Metformin; Mice; Mice, Inbred BALB C; Mice, Transgenic; Phosphorylation; T-Lymphocytes, Regulatory | 2015 |
Targeting Metabolism as a Platform for Inducing Allograft Tolerance in the Absence of Long-Term Immunosuppression.
Topics: Abatacept; Allografts; Animals; Deoxyglucose; Diazooxonorleucine; Glycolysis; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Metformin; Mice; T-Lymphocytes; Transplantation Tolerance | 2020 |